JPMorgan is one of the major mutual fund managers in the United States and prides itself for being the nation’s leader in equity fund flows. JPMorgan offers managed accounts and retirement products. Its primary principle is to understand the needs of its clients and advice the best investment solutions for surplus returns.
Also, JPMorgan is one of the best financial management companies in the world. It has a legacy of investment management since 1865. The company pioneered innovative, inflation-protected municipal products. J.P. Morgan managed $1.71 billion of assets as of Sep 30, 2018. The fund family has offices in more than 30 countries.
Below we share with you three top-ranked JPMorgan mutual funds. Each has earned a Zacks Mutual Fund Rank #1 (Strong Buy) and is expected to outperform its peers in the future. Investors can click here to see the complete list of JPMorgan funds.
JPMorgan Intrepid Value A (JIVAX - Free Report) seeks appreciation of capital for the long run. The fund invests a large chunk of its assets in equity securities of large- and mid-cap companies that have attractive valuations. JPMorgan Intrepid Value A has one-year annualized returns of 5%.
JIVAX has an expense ratio of 0.83% compared with the category average of 1.00%.
JPMorgan Intrepid GrowthFund A (JIGAX - Free Report) seeks to offer growth of capital for the long run. JIGAX invests primarily in a broad portfolio of equity securities of large- and mid-cap companies that have high quality and attractive valuations. JPMorgan Intrepid Growth Fund A has one-year annualized returns of 8.1%.
Jason Alonzo is one of the fund managers of JIGAX since 2005.
JPMorgan Small Cap Growth Fund A (PGSGX - Free Report) invests the lion’s share of its assets in securities issued by small-cap companies. These are companies with market capitalization equivalent to those listed on the Russell 2000 Growth Index stocks and below $4 billion at the time of purchase. The fund seeks capital appreciation for the long run. JPMorgan Small Cap Growth Fund A has one-year annualized returns of 10.8%.
As of September 2018, PGSGX held 117 issues, with 2.11% of its assets invested in Teladoc Health Inc.
To view the Zacks Rank and past performance of all JPMorgan mutual funds, investors can click here to see the complete list of JPMorgan funds.
Want key mutual fund info delivered straight to your inbox?
Zacks’ free Fund Newsletter will brief you on top news and analysis, as well as top-performing mutual funds, each week. Get it free >>
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
JPMorgan is one of the major mutual fund managers in the United States and prides itself for being the nation’s leader in equity fund flows. JPMorgan offers managed accounts and retirement products. Its primary principle is to understand the needs of its clients and advice the best investment solutions for surplus returns.
Also, JPMorgan is one of the best financial management companies in the world. It has a legacy of investment management since 1865. The company pioneered innovative, inflation-protected municipal products. J.P. Morgan managed $1.71 billion of assets as of Sep 30, 2018. The fund family has offices in more than 30 countries.
Below we share with you three top-ranked JPMorgan mutual funds. Each has earned a Zacks Mutual Fund Rank #1 (Strong Buy) and is expected to outperform its peers in the future. Investors can click here to see the complete list of JPMorgan funds.
JPMorgan Intrepid Value A (JIVAX - Free Report) seeks appreciation of capital for the long run. The fund invests a large chunk of its assets in equity securities of large- and mid-cap companies that have attractive valuations. JPMorgan Intrepid Value A has one-year annualized returns of 5%.
JIVAX has an expense ratio of 0.83% compared with the category average of 1.00%.
JPMorgan Intrepid GrowthFund A (JIGAX - Free Report) seeks to offer growth of capital for the long run. JIGAX invests primarily in a broad portfolio of equity securities of large- and mid-cap companies that have high quality and attractive valuations. JPMorgan Intrepid Growth Fund A has one-year annualized returns of 8.1%.
Jason Alonzo is one of the fund managers of JIGAX since 2005.
JPMorgan Small Cap Growth Fund A (PGSGX - Free Report) invests the lion’s share of its assets in securities issued by small-cap companies. These are companies with market capitalization equivalent to those listed on the Russell 2000 Growth Index stocks and below $4 billion at the time of purchase. The fund seeks capital appreciation for the long run. JPMorgan Small Cap Growth Fund A has one-year annualized returns of 10.8%.
As of September 2018, PGSGX held 117 issues, with 2.11% of its assets invested in Teladoc Health Inc.
To view the Zacks Rank and past performance of all JPMorgan mutual funds, investors can click here to see the complete list of JPMorgan funds.
Want key mutual fund info delivered straight to your inbox?
Zacks’ free Fund Newsletter will brief you on top news and analysis, as well as top-performing mutual funds, each week. Get it free >>
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Get the latest research report on JIGAX - FREE
Get the latest research report on JIVAX - FREE
Get the latest research report on PGSGX - FREE